CLSD
Clearside Biomedical Inc
Halal Rating :
Last Price
$0.93
Last updated:
Market Cap
-
7D Change
0.03%
1 Year Change
-22.51%
Company Overview
Industries
Exchange
Next Earnings Date
Clearside Biomedical Inc is a biopharmaceutical company developing treatments for serious eye diseases. The company's primary focus is on developing innovative therapies using its proprietary SCS Microinjector® platform to deliver drugs to the suprachoroidal space in the eye. Their lead product candidate is CLS-AX (axitinib injectable suspension) for the treatment of wet age-related macular degeneration.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $1.04m | $9.43m | - | $2.46m | 0.00% | 26.06% |
| June 30, 2024 | $90000.0 | $10.02m | - | $2.34m | 0.00% | 23.35% |
| March 31, 2024 | $230000.0 | $10.84m | - | $2.4m | 0.00% | 22.16% |
Company Impact
Help us evaluate Clearside Biomedical Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.